By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
PR Newswire GAITHERSBURG, Md., Sept. 13, 2024 GAITHERSBURG, Md., Sept. 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the ...
PR Newswire KING OF PRUSSIA, Pa. and SAN DIEGO, Sept. 13, 2024 Approval underscores CSL and Arcturus Therapeutics' commitment to delivering disruptive technologies to combat COVID-19 and other respiratory viral diseases to protect public ...
PR Newswire LOS ANGELES, Sept. 12, 2024 Tammy Gold rebrands as Therapeutic Parenting Method to offer evidence-based, empathetic support for post-COVID parental mental health challenges LOS ANGELES, Sept. 12, 2024 /PRNewswire-PRWeb/ ...
PR Newswire LOS ANGELES, Sept. 12, 2024 Individuals vaccinated at these events will receive a $20 grocery gift card, while supplies last LOS ANGELES, Sept. 12, 2024 /PRNewswire/ -- L.A. Care Health Plan and Blue Shield of California ...
PR Newswire BOSTON, Sept. 11, 2024 Considering the major societal disruptions brought on by government mandates responding to the COVID19 pandemic, all communities owe their residents an objective review of the mandates imposed. BOSTON, ...
PR Newswire SEOUL, South Korea, Sept. 11, 2024 SEOUL, South Korea, Sept. 11, 2024 /PRNewswire/ -- Dr. Heung-Jeong Woo, a vice president of Hyundai Bioscience shared insights on the current state of antiviral treatments at the "Disease ...
PR Newswire CUPERTINO, Calif., Sept. 10, 2024 CUPERTINO, Calif., Sept. 10, 2024 /PRNewswire/ -- Oneness Biotech and Microbio (Shanghai) announced that the pan-COVID New Drug, SNS812, co-developed by both companies achieves statistical ...
PR Newswire BOSTON, Sept. 10, 2024 CMV is known to be present in semen of HIV-infected men, factors leading to shedding of each virus are unknown. Studies determining the efficacy of adding anti-CMV treatment strategies to HAART on lowering ...
PR Newswire SAN ANTONIO, Sept. 5, 2024 Antibody SC27 developed in part by Associate Professor based at Texas Biomedical Research Institute SAN ANTONIO, Sept. 5, 2024 /PRNewswire/ -- A discovery led in part by a Texas Biomedical Research ...
PR Newswire SEATTLE, Sept. 5, 2024 InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
White blood cell counts or leukocytes could be a crucial indicator of COVID-19 severity in women, impacting treatment strategies, stated new research.
Nearly 70% of patients report lingering symptoms of Long-COVID, highlighting its widespread impact and need for ongoing research and care solutions.
Newly developed vaccine could protect against emerging SARS-CoV-2 variants and related coronaviruses that may jump from animals to humans.
AI reveals hidden care needs in Long COVID patients, helping physicians offer targeted treatments and improve patient outcomes with personalized care strategies.
Human Metapneumovirus (HMPV) is causing respiratory issues in China, with flu-like symptoms, spreading through droplets. Precautionary measures include hygiene and masks.
Subscribe to our Free Newsletters!